Adenoviral vectors are increasingly recognized as powerful tools in gene therapy and vaccine development. These vectors, derived from adenoviruses, can deliver genetic material into cells, making ...

Adenoviruses (Ad) are currently the most commonly used vectors in gene therapy clinical ... efficacy of the vector and causes toxic side effects. The 46 kDa coxsackie and adenovirus receptor ...

Exposing Adenoviruses: Inder Verma and colleagues used nude mice to study immune system and humoral responses during gene therapy ... immune responses to adenoviral vectors containing factor IX gene: ...

Recurrent respiratory papillomatosis (RRP) is a disease of the upper airway presenting with exophytic wart-like lesions. These lesions are considered benign with less than a 1–5% chance of malignant ...

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

Intraperitoneal delivery of adenoviral gene therapy in vivo is safe and nontoxic. The use of new diluents, already used in peritoneal renal dialysis, will improve drug delivery, reduce therapeutic ...

The companies will work together by using the codon-optimized BBS1 AAV9 vector to minimize the vision loss caused by the ...

Adenoviruses offer powerful gene delivery capabilities ... and easy selection of the successful clones. 1 To use the kit, the cDNA of interest is first cloned into a transfer vector before ...

For recurrent respiratory papillomatosis (RRP), novel gene therapy to jump-start immunity to the human papillomavirus (HPV) ...

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...